{
    "nct_id": "NCT04414397",
    "official_title": "A Multicenter, Evaluator-blinded, Randomized, Parallel-group, Controlled Study of the Safety and Effectiveness of JUVÉDERM® VOLUMA® XC Injectable Gel for Correction of Temple Hollowing",
    "inclusion_criteria": "* Participants in general good health\n* Participants seeking improvement of temple hollowing\nHealthy volunteers allowed\nMust have minimum age of 22 Years",
    "exclusion_criteria": "* Temple hollowing due to trauma, congenital malformations, or lipodystrophy\n* Temporomandibular joint dysfunction or any other jaw issues\n* Recurrent temporal headaches such as temporal tendinitis migraine\n* Active autoimmune disease\n* History of anaphylaxis or allergy to lidocaine (or any amide-based anesthetics), HA products, or Streptococcal protein\n* Prior facial reconstructive surgeries, facelift, or browlift as well as surgeries on the temple area (eg, biopsy)\n* Fat injection or permanent facial implants anywhere in the face\n* Semipermanent soft-tissue filler treatment in the temple or mid-face within 36 months before enrollment\n* Temporary dermal filler injections above the subnasale within 24 months before enrollment\n* Mesotherapy or cosmetic facial procedures above the subnasale within 6 months before enrollment\n* Botulinum toxin treatment above the subnasale within 6 months before enrollment\n* Females who are pregnant, nursing, or planning a pregnancy",
    "miscellaneous_criteria": ""
}